MINI FUTURE SHORT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000PE8VQ77

Real-time Boerse Frankfurt Warrants 14:21:18 17/06/2024 BST
1.52 EUR +9.35% Intraday chart for MINI FUTURE SHORT - FRESENIUS MEDICAL CARE
Current month+5.30%
1 month+8.59%
Date Price Change
17/06/24 1.52 +9.35%
14/06/24 1.39 +1.46%
13/06/24 1.37 +9.60%
12/06/24 1.25 -5.30%
11/06/24 1.32 +1.54%

Real-time Boerse Frankfurt Warrants

Last update June 17, 2024 at 02:21 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE8VQ7
ISINDE000PE8VQ77
Date issued 09/02/2023
Strike 52.35
Maturity Unlimited
Parity 10 : 1
Emission price 1.83
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.29
Lowest since issue 0.43
Spread 0.01
Spread %0.66%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.63 EUR
Average target price
39.97 EUR
Spread / Average Target
+3.48%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW